These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Pegylated intereferon hematological safety in comparison with standard].
    Author: Fazylov VKh, Manapova ÉR, Tkacheva SV, Sozinova IuM.
    Journal: Eksp Klin Gastroenterol; 2012; (6):96-9. PubMed ID: 23402198.
    Abstract:
    Comparative analysis of adverse hematologic effects in 135 patients with with chronic hepatits C on combined antiviral therapy of pegylated and "short lived" forms of alpha-interferon in combination with ribavirin was investigated. As a result of the comparison, the response to antiviral therapy in patients with chronic hepatitis C treated with daily administration of simple interferon-alpha in hematologic data is similar in patients undergoing treatment with pegylated drugs.
    [Abstract] [Full Text] [Related] [New Search]